Service de Réanimation médicale
Strasbourg, 67091, France
Completed
NCT Number: NCT03452631
Spontaneous Haematomas of Psoas Occurring in Intensive Care
Psoas hematomas are a rare and potentially lethal pathology whose incidence in resuscitation is unknown. The pathophysiology of this pathology is not known to date.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Major patients
- Psoas hematoma diagnosed during hospitalization
Exclusion criteria
- Refusal to participate in the study
Treatment and study plan
Primary outcomes
-
Number of psoas hematomas
Time frame: 72 hours after admission to intensive care
Sponsors and collaborators
Lead sponsor
University Hospital, Strasbourg, France
Other
Registry information
Official study title
Spontaneous Haematomas of Psoas Occurring in Intensive Care: Incidence, Patient Characteristics and Treatment, a Retrospective Study
Important dates
- Study start
- 2017
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Mar 2, 2018
- Registry last updated
- Jul 1, 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.